60
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Long Non-Coding RNA AC118344.1 Promotes Gastric Cancer Cell Proliferation, Invasion, and Metastasis via AKT2 and Its Downstream Molecules HK2 and MMP2

, , &
Pages 12613-12621 | Published online: 08 Dec 2020

References

  • Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534–542. doi:10.1016/j.cgh.2019.07.04531362118
  • Sano T. Gastric cancer: Asia and the world. Gastric Cancer. 2017;20:1–2. doi:10.1007/s10120-017-0694-9
  • Biagioni A, Skalamera I, Peri S, et al. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev. 2019;38:537–548.31486976
  • Shariati M, Meric-Bernstam F. Targeting AKT for cancer therapy. Expert Opin Investig Drugs. 2019;28:977–988. doi:10.1080/13543784.2019.1676726
  • Mirza M, Ekrami EM, Aghdas SAM, et al. Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: implication for cancer therapy. Life Sci. 2020;255:117481. doi:10.1016/j.lfs.2020.11748132135183
  • Noorolyai S, Shajari N, Baghbani E, et al. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128. doi:10.1016/j.gene.2019.02.07630849534
  • Yang Q, Zhang RW, Sui PC, et al. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol. 2015;21:10956–10981.26494954
  • Wu Y, Qian Z. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma. Discov Med. 2019;28:129–138.31926584
  • Zong W, Ju S, Jing R, et al. Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer. Clin Chem Lab Med. 2018;56:1828–1837. doi:10.1515/cclm-2017-113929804098
  • Zhang J, Zhang J, Qiu W, et al. MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2. Am J Cancer Res. 2017;7:1835–1849.28979807
  • Ma X, Zhuang B, Li W. MicroRNA2965p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion. Mol Med Rep. 2017;16:1565–1572. doi:10.3892/mmr.2017.670128586057
  • Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661–5667. doi:10.1038/onc.2017.18428604750
  • Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261. doi:10.1038/nm.398126540387
  • Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452–463. doi:10.1016/j.ccell.2016.03.01027070700
  • Zhang Y, Xiang C, Wang Y, et al. lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway. Biomed Pharmacother. 2017;94:644–651. doi:10.1016/j.biopha.2017.07.12028787699
  • Zheng B, Geng L, Zeng L, et al. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-kappaB axis. Cell Signal. 2018;45:122–131. doi:10.1016/j.cellsig.2018.01.02129374601
  • Li H, Lu S, Chen Y, et al. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation. Cell Signal. 2019;58:99–110. doi:10.1016/j.cellsig.2019.03.01130877036
  • Hers I, Vincent EE, Tavare JM. Akt signalling in health and disease. Cell Signal. 2011;23:1515–1527. doi:10.1016/j.cellsig.2011.05.00421620960
  • Hinz N, Jucker M. Distinct functions of AKT isoforms in breast cancer: a comprehensive review. Cell Commun Signal. 2019;7:154.
  • Miyoshi T, Umemura S, Matsumura Y, et al. Genomic profiling of large-cell neuroendocrine carcinoma of the lung. Clin Cancer Res. 2017;23:757–765. doi:10.1158/1078-0432.CCR-16-035527507618
  • Ding Z, Xu F, Li G, et al. Knockdown of Akt2 expression by shRNA inhibits proliferation, enhances apoptosis, and increases chemosensitivity to paclitaxel in human colorectal cancer cells. Cell Biochem Biophys. 2015;71:383–388. doi:10.1007/s12013-014-0209-925134663
  • Gong JN, Yu J, Lin HS, et al. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Cell Death Differ. 2014;21:100–112. doi:10.1038/cdd.2013.13324076586
  • Zhou B, Shan H, Su Y, et al. Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma. Oncotarget. 2017;8:69746–69755. doi:10.18632/oncotarget.1926129050238
  • Chan JJ, Tay Y. Noncoding RNA: RNA regulatory networks in cancer. Int J Mol Sci. 2018;19(5):1310. doi:10.3390/ijms19051310
  • Sanchez A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109:2093–2100. doi:10.1111/cas.1364229774630
  • Zhang L, Wang Y, Su H. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway. Neoplasma. 2020;67(04):762–772. doi:10.4149/neo_2020_190706N59832726126
  • Wang SH, Wu XC, Zhang MD, et al. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Tumour Biol. 2016;37:9721–9730. doi:10.1007/s13277-016-4852-126803515
  • Dong Y, Huo X, Sun R, et al. lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor miR-615-5p. Biosci Rep. 2018;38. doi:10.1042/BSR20181150